Maylis joined Kurma Partners in 2022 and is an Associate based in Paris. She is part of the Kurma Growth Opportunities Fund, which aims to invest into maturing European companies, across the Biotech and HealthTech sectors. Maylis is a scientist by training, she graduated from King’s College London in Biomedical Science with a focus on immuno-oncology, and Essec Business School in Strategy and Finance.